| Literature DB >> 33186391 |
Paola Michieletto1, Stefano Pensiero2, Laura Diplotti2, Luca Ronfani3, Manuela Giangreco3, Alberto Danieli4, Paolo Bonanni4.
Abstract
PURPOSE: To report and evaluate strabismus surgery in children with Angelman syndrome, in order to optimize and standardize surgical approach. Other purposes are to understand the possible relation between ocular findings and motor ability, and between improvement in ocular alignment and changes in motor skills in this population.Entities:
Year: 2020 PMID: 33186391 PMCID: PMC7665582 DOI: 10.1371/journal.pone.0242366
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Ophthalmologic characteristics of the enrolled population.
| ID | Class | Gen | Age (y) | RE refractive error (D) | LE refractive error (D) | B BCVA | Pre-op dev (PD) | Type and amount of surgery (mm) | Post-op dev (PD) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | I | F | 13 | +2.00 | +2.00 | / | +18 | RE | RE: MR rec 5 | ort | |
| 2 | I | F | 9 | +1.00 +2.00/90 | +0.50 +1.25/95 | / | -40 | int | B: LR rec 8 | ort | |
| 3 | I | F | 12 | +2.50 | +2.00 +1.00/100 | / | -45 | alt | B: LR rec 8 | -25 | alt |
| 4 | I | M | 8 | +1.50 +2.50/90 | +1.50 +3.50/75 | / | -45 | alt | B: LR rec 8 | -20 | alt |
| 5 | I | F | 9 | -1.25 +2.50/110 | +0.25 +1.25/60 | / | -35 | LE | B: LR rec 7 | -12 | LE |
| 6 | I | M | 13 | +3.00 +0.50/80 | +2.00 +1.50/80 | / | -35 | LE | B: LR rec 7 | -25 | LE |
| 7 | I | M | 3 | +1.50 +1.00/100 | +1.50 +1.25/80 | / | -30 | int | B: LR rec 7 | ort | |
| 8 | I | F | 12 | +2.50 +4.00/100 | +2.75 +3.75/70 | / | -30 | RE | B: LR rec 7 | -12 | RE |
| 9 | I | F | 9 | +1.50 +2.50/90 | -3.00 +3.50/180 | / | -45 | RE | B: LR rec 8 | -16 | RE |
| 10 | I | M | 14 | +1.25 +2.75/105 | +1.25 +2.25/90 | / | -30 | LE, ny | LE: LR rec 6, MR res 4 | ort | |
| 11 | I | F | 8 | -3.25 +3.25/120 | -2.00 +2.25/105 | / | -60 | RE | B: LR rec 8, MR res 4 | -14 | RE |
| 12 | I | F | 5 | +0.25 +2.50/105 | +1.00 +2.50/95 | / | -50 | int, V | B: LR rec 8, B: IO rec | ort | |
| 13 | II | F | 9 | +1.50 | +1.25 | 20/25 | -30 | int | B: LR rec 7 | ort | |
| 14 | III | M | 8 | +1,00 +0.75/100 | +0.50 +1.00/105 | / | -25 | int | B: LR rec 6 | ort | |
| 15 | IV | F | 9 | -0.50 | -0.25 | 20/40 | -20 | int | B: LR rec 5 | ort | |
| 16 | IV | M | 4 | +4.50 +1.25/90 | +3.50 +2.25/100 | / | +12 | V | LE: MR rec 4, B: IO rec | ort | |
| 17 | IV | M | 15 | -1.50 +1.50/80 | -1.50/170 | 20/50 | +30 | B: MR rec 4.5 | ort | ||
ID = patients’ identification number; Class = genotype (genetic mechanisms causing Angelman syndrome); Gen = gender; F = female; M = male; y = years; RE = right eye; LE = left eye; B = bilateral; Pre-op = pre-operative; Post-op = post-operative (1 year after operation); dev = deviation; D = dioptres; PD = prism dioptres; BCVA = best corrected visual acuity; int = intermittent; V = V pattern; ny = nystagmus; MR = medial rectus muscle; LR = lateral rectus muscle; IO = inferior oblique muscle; rec = recession; res = resection, ort = orthotropia (deviation < 8 PD); alt = alternating; / = not available
Class: I–de novo interstitial deletions on maternally-inherited chromosome 15q11.2–13.3; II–paternal uniparental disomy of chromosome 15; III–paternal imprinting disorders in chromosome 15; IV–point mutations in the maternally-inherited UBE3A gene.
Positive numbers refer to esodeviations; negative numbers to exodeviations.
Motor development assessment in the enrolled population.
| ID | Class | Gen | Age (y) | GMFMS | BSID-III | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LyR (%) | Si (%) | CK (%) | St (%) | WRJ (%) | TS (%) | TS (%) | |||||||||||
| pre | post | pre | post | pre | post | pre | post | pre | post | pre | post | pre | post | ||||
| 1 | I | F | 13 | 94 | 88 | 97 | 85 | 93 | 79 | 72 | 59 | 35 | 36 | 78 | 69 | 21 | / |
| 2 | I | F | 9 | 88 | / | 70 | / | 7 | / | 15 | / | 6 | / | 37 | / | 26 | / |
| 3 | I | F | 12 | 100 | 100 | 95 | 98 | 71 | 79 | 74 | 74 | 56 | 60 | 79 | 82 | 40 | 40 |
| 4 | I | M | 8 | 76 | 76 | 72 | 85 | 7 | 7 | 67 | 72 | 31 | 40 | 51 | 56 | 26 | 26 |
| 5 | I | F | 9 | 88 | 88 | 72 | 73 | 14 | 12 | 13 | 13 | 13 | 14 | 40 | 40 | 21 | 21 |
| 6 | I | M | 13 | 100 | / | 100 | / | 86 | / | 74 | / | 53 | / | 83 | / | 26 | 30 |
| 7 | I | M | 3 | 98 | / | 60 | / | 7 | / | 10 | / | 8 | / | 37 | / | 26 | 29 |
| 8 | I | F | 12 | 88 | 94 | 98 | 98 | 71 | 79 | 67 | 72 | 36 | 53 | 72 | 79 | 28 | 30 |
| 9 | I | F | 9 | 75 | 76 | 20 | 20 | 5 | 5 | 0 | 0 | 0 | 0 | 20 | 20 | 21 | 23 |
| 10 | I | M | 14 | 100 | / | 100 | / | 81 | / | 79 | / | 60 | / | 84 | / | 38 | / |
| 11 | I | F | 8 | 100 | 100 | 73 | 73 | 7 | 7 | 54 | 59 | 50 | 50 | 57 | 58 | 28 | 30 |
| 12 | I | F | 5 | / | / | / | / | / | / | / | / | / | / | / | / | / | / |
| 13 | II | F | 9 | / | / | / | / | / | / | / | / | / | / | / | / | / | / |
| 14 | III | M | 8 | 100 | / | 100 | / | 100 | / | 77 | / | 42 | / | 84 | / | 40 | / |
| 15 | IV | F | 9 | 100 | 100 | 100 | 100 | 86 | 95 | 85 | 85 | 71 | 75 | 88 | 91 | 47 | 47 |
| 16 | IV | M | 4 | 100 | 100 | 85 | 100 | 74 | 88 | 69 | 72 | 28 | 51 | 71 | 82 | 30 | 38 |
| 17 | IV | M | 15 | / | / | / | / | / | / | / | / | / | / | / | / | / | / |
ID = patients’ identification number; Class = genotype (genetic mechanisms causing Angelman syndrome); Gen = gender; F = female; M = male; y = years; GMFMS = Gross Motor Function Measure Scale; BSID-III = Bayley scales of infant and toddler development, 3rd edition; LyR = Lying and Rolling; Si = Sitting; CK = Crawling and Kneeling; St = Standing; WRJ = Walking, running and jumping; TS = Total score; pre = pre-operative; post = post-operative (3 months after operation); / = not available.
Class: I–de novo interstitial deletions on maternally-inherited chromosome 15q11.2–13.3; II–paternal uniparental disomy of chromosome 15; III–paternal imprinting disorders in chromosome 15; IV–point mutations in the maternally-inherited UBE3A gene.